To the Editor: We read with interest the article by Kelly and colleagues,1 In our opinion, the authors’ statement “Access to timely gender‐affirming care is associated with improved mental health outcomes and overall wellbeing” is not well supported by the two citations provided.
The full article is accessible to AMA members and paid subscribers. Login to read more or purchase a subscription now.
Please note: institutional and Research4Life access to the MJA is now provided through Wiley Online Library.
- 1. Kelly F, Giordano S, Telfer MM, Pang KC. Parental consent and the treatment of transgender youth: the impact of Re Imogen. Med J Aust 2022; 216: 219‐221. https://www.mja.com.au/journal/2022/216/5/parental‐consent‐and‐treatment‐transgender‐youth‐impact‐re‐imogen
- 2. Rew L, Young CC, Monge M, Bogucka R. Review: puberty blockers for transgender and gender diverse youth — a critical review of the literature. Child Adolesc Ment Health 2021; 26: 3‐14.
- 3. Clayton A, Malone WJ, Clarke P, et al. Commentary: the signal and the noise‐questioning the benefits of puberty blockers for youth with gender dysphoria‐a commentary on Rew et al. Child Adolesc Ment Health 2021; https://doi.org/10.1111/camh.12533 [Epub ahead of print].
- 4. Rew L, Young CC, Monge M, Bogucka R. Response: “the signal and the noise” — a response to Clayton et al. Child Adolesc Ment Health 2021; https://doi.org/10.1111/camh.12534 [Epub ahead of print].
- 5. Mahfouda S, Moore JK, Siafarikas A, et al. Gender‐affirming hormones and surgery in transgender children and adolescents. Lancet Diabetes Endocrinol 2019; 7: 484‐498.
- 6. National Institute for Health and Care Excellence. Evidence review: gonadotrophin releasing hormone analogues for children and adolescents with gender dysphoria. NICE, 2020. https://web.archive.org/web/20220414202655/https://arms.nice.org.uk/resources/hub/1070905/attachment (viewed May 2022).
- 7. National Institute for Health and Care Excellence. Evidence review: gender‐affirming hormones for children and adolescents with gender dysphoria. NICE, 2020. https://web.archive.org/web/20220215111922/https://arms.nice.org.uk/resources/hub/1070871/attachment (viewed May 2022).
- 8. Cass H. The Cass Review: independent review of gender identity services for children and young people — interim report. Cass Review, 2022. https://cass.independent‐review.uk (viewed May 2022).
Online responses are no longer available. Please refer to our instructions for authors page for more information.
Alison Clayton and Patrick Clarke are affiliated with the Society for Evidence‐based Gender Medicine (SEGM). Roberto D'Angelo is a clinical and academic advisor to SEGM.